Expression of an antisense transforming growth factor-beta1 transgene reduces tumorigenicity of EMT6 mammary tumor cells.

Park, J A; Wang, E; Kurt, R A; Schluter, S F; Hersh, E M; Akporiaye, E T

Park, J A; Wang, E; Kurt, R A; Schluter, S F; Hersh, E M; Akporiaye, E T.

Affiliation

Park JA; Department of Microbiology and Immunology, The University of Arizona, Tucson 85724, USA.

Cancer Gene Ther ; 4(1): 42-50, 1997.

Article in En | MEDLINE | ID: mdl-9012450

Subject(s)

Gene Expression; Mammary Neoplasms, Experimental/pathology; Oligonucleotides, Antisense/genetics; Transforming Growth Factor beta/genetics; Transgenes; Animals; Cell Cycle/genetics; Cell Cycle/immunology; Cell Division/genetics; Cell Division/immunology; Female; Immune Tolerance; Mice; Mice, Inbred BALB C; Transforming Growth Factor beta/physiology; Tumor Cells, Cultured

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Gene Expression / Oligonucleotides, Antisense / Transforming Growth Factor beta / Transgenes / Mammary Neoplasms, Experimental Limits: Animals Language: En Year: 1997 Type: Article

Search on Google

XML

PubMed Links